Literature DB >> 16429495

A single mutation near the C-terminus in alpha/beta hydrolase fold protein family causes a defect in protein processing.

Antonella De Jaco1, Zrinka Kovarik, Davide Comoletti, Lori L Jennings, Guido Gaietta, Mark H Ellisman, Palmer Taylor.   

Abstract

An Arg to Cys mutation in the extracellular domain of neuroligin-3 (NL3) was recently found in a twin set with autism [S. Jamain, H. Quach, C. Betancur, M. Rastam, C. Colineaux, I.C. Gillberg, H. Soderstrom, B. Giros, M. Leboyer, C. Gillberg, T. Bourgeron, Paris Autism Research International Sibpair Study, mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism, Nat. Genet. 34 (2003) 27-29]. The Cys substitution in NL3 causes altered intracellular protein trafficking, intracellular retention and diminished association with its cognate partner, beta-neurexin [D. Comoletti, A. De Jaco, L.L. Jennings, R.E. Flynn, G. Gaietta, I. Tsigelny, M.H. Ellisman, P. Taylor, The R451C-neuroligin-3 mutation associated with autism reveals a defect in protein processing, J. Neurosci. 24 (2004) 4889-4893]. NL3, butyrylcholinesterase (BuChE), and acetylcholinesterase (AChE), as members of the (/(-hydrolase fold family of proteins, share over 30% of amino acid identity in their extracellular domains. In particular, Arg451 in NL3 is conserved in the alpha/beta-hydrolase fold family being homologous to Arg386 in BuChE and Arg395 in AChE. A Cys substitution at the homologous Arg in the BuChE was found studying post-succinylcholine apnea in an Australian population [T. Yen, B.N. Nightingale, J.C. Burns, D.R. Sullivan, P.M. Stewart, Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population, Clin. Chem. 49 (2003) 1297-308]. We have made the homologous mutation in the mouse AChE and BuChE genes and showed that the Arg to Cys mutations resulted in identical alterations in the cellular phenotype for the various members of the alpha/beta-hydrolase fold family proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16429495     DOI: 10.1016/j.cbi.2005.10.057

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  4 in total

1.  Expression of neurexin, neuroligin, and their cytoplasmic binding partners in the pancreatic beta-cells and the involvement of neuroligin in insulin secretion.

Authors:  Arthur T Suckow; Davide Comoletti; Megan A Waldrop; Merrie Mosedale; Sonya Egodage; Palmer Taylor; Steven D Chessler
Journal:  Endocrinology       Date:  2008-08-28       Impact factor: 4.736

2.  Synaptic recognition molecules in development and disease.

Authors:  Dhrubajyoti Chowdhury; Katherine Watters; Thomas Biederer
Journal:  Curr Top Dev Biol       Date:  2021-02-12       Impact factor: 4.897

Review 3.  Genetic aspects of autism spectrum disorders: insights from animal models.

Authors:  Swati Banerjee; Maeveen Riordan; Manzoor A Bhat
Journal:  Front Cell Neurosci       Date:  2014-02-24       Impact factor: 5.505

4.  Autism-associated variants of neuroligin 4X impair synaptogenic activity by various molecular mechanisms.

Authors:  Takafumi Yumoto; Misaki Kimura; Ryota Nagatomo; Tsukika Sato; Shun Utsunomiya; Natsue Aoki; Motoji Kitaura; Koji Takahashi; Hiroshi Takemoto; Hirotaka Watanabe; Hideyuki Okano; Fumiaki Yoshida; Yosuke Nao; Taisuke Tomita
Journal:  Mol Autism       Date:  2020-09-01       Impact factor: 7.509

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.